SVRA

Savara, Inc. - Common Stock (SVRA)

About Savara, Inc. - Common Stock (SVRA)

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Details

Daily high

$2.18

Daily low

$2.02

Price at open

$2.05

52 Week High

$5.11

52 Week Low

$1.89

Market cap

357.8M

Dividend yield

0.00%

Volume

886,444

Avg. volume

2.6M

P/E ratio

-4.19

Savara, Inc. - Common Stock News